NASDAQ: BLU - BELLUS Health Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart BELLUS Health Inc.

Extended chart Simple chart
Financial Markets by TradingView

About BELLUS Health Inc.

BELLUS Health Inc., клиническая биофармацевтическая компания, разрабатывает терапевтические средства для лечения хронического кашля и других расстройств гиперчувствительности. Его ведущий кандидат на препарат включает BLU-5937, пероральный мелкомолекулярный антагонист рецептора P2X3, который находится в фазе II клинических испытаний для лечения хронического кашля и хронического зуда. BELLUS Health Inc. была основана в 1993 году со штаб-квартирой в Лавале, Канада.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2008-12-29
ISIN CA07987C2040
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0.2438
Дивиденд ао 0.0159
Сайт http://www.bellushealth.com
Цена ао 14.74
Change price per day: 0% (14.74)
Change price per week: 0% (14.74)
Change price per month: 0% (14.74)
Change price per 3 month: 0% (14.74)
Change price per half year: 0% (14.74)
Change price per year: 0% (14.74)
Change price per 3 year: +123.33% (6.6)
Change price per 5 year: +47.4% (10)
Change price per 10 year: 0% (14.74)
Change price per year to date: 0% (14.74)
All parameters

Underestimation

Title Value Grade
P/S 61933.24 1
P/BV 2.53 6
P/E 0 0
EV/EBITDA -12.44 0
Total: 2.75

Efficiency

Title Value Grade
ROA, % -21.21 0
ROE, % -22.28 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.5714 5.71
Total: 0.8157

Debt

Title Value Grade
Debt/EBITDA -0.0179 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % -44.44 0
Yield Ebitda, % 232.66 10
Yield EPS, % 16.87 3
Total: 6.6
More

Institutions Volume Share, %
RA Capital Management, L.P. 12643574 9.97
Goldman Sachs Group Inc 7413933 5.85
Pictet Asset Management SA 7072143 5.58
COMMODORE CAPITAL LP 6579359 5.19
Orbimed Advisors LLC. 5108900 4.03
Perceptive Advisors LLC 4952538 3.91
Power Corp of Canada 4937730 3.89
Laurion Capital Management, LP 4833580 3.81
Avidity Partners Management, LP 4553577 3.59
Citadel Advisors Llc 4290398 3.38

ETFShare, %Profitability for 1 year, %Dividends, %
SPDR Portfolio Emerging Markets ETF 0.00441 11.59 3.1879
0.0000011.593.19



Head Job title Payment Year of birth
Mr. Roberto Francesco Bellini Pres, CEO & Director 790.35k 1980 (45 years)
Mr. Ramzi Benamar Chief Financial Officer 650.48k 1973 (52 years)
Mr. Daniel Matthews Director of Investor Relations & Communications N/A
Mr. Sebastien Roy Corp. Sec. N/A 1976 (49 years)
Mr. Tony Matzouranis Sr. VP of Bus. Devel. N/A 1973 (52 years)
Dr. Catherine M. Bonuccelli M.D. Chief Medical Officer 741.66k 1958 (67 years)
Dr. Andreas Orfanos FFPM, M.B.B.Ch, MBA Chief Operating Officer 417.58k 1959 (66 years)
Dr. Denis Garceau Chief Scientific Officer 1957 (68 years)
Mr. Francois Desjardins C.A., CPA, CPA, CA Sr. VP of Fin. 1963 (62 years)

Address: Canada, Laval, QC HV A, 275 Armand-Frappier Boulevard - open in Google maps, open in Yandex maps
Website: http://www.bellushealth.com